Tonix Pharmaceuticals Holding Corp said on Tuesday its experimental drug failed to meet the primary goal in a mid-stage study for management of widespread muscle pain and tenderness associated with long Covid-19.
Due to the low demand for consumer electronics, price competition among China-based MCU suppliers is becoming increasingly fierce, according to industry sources in Taiwan. Taiwan-based MCU providers have long been preparing to respond to price competition.
Item 3.03 Material Modification to Rights of Security Holders.
The Board of Directors of Tonix Pharmaceuticals Holding Corp., a Nevada
corporation , has approved a reverse stock split of the. | May 9, 2023
Demand for MCU, after hitting the bottom in the first quarter, is expected to start picking up in the second quarter with China s recovery from the COVID-19 pandemic, according to sources from the upstream supply chain.
Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, today announced that it has entered into a sponsored research agreement with the University of Maryland, Baltimore ,. | February 2, 2023